Novel Spot Tests for Detecting the Presence of Zinc Sulfate in Urine, a Newly Introduced Urinary Adulterant to Invalidate Drugs of Abuse Testing
|
|
- Gervais Bell
- 5 years ago
- Views:
Transcription
1 Novel Spot Tests for Detecting the Presence of Zinc Sulfate in Urine, a Newly Introduced Urinary Adulterant to Invalidate Drugs of Abuse Testing Kerry J. Welsh, MD, PhD, Jennifer E. Dierksen, MD, Jeffrey K. Actor, PhD, and Amitava Dasgupta, PhD From the Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Houston, TX. CME/SAM Key Words: Spot test; Zinc sulfate; Adulterated urine; False negative DOI: /AJCP2FJ9VBPXJYTQ ABSTRACT Objectives: To find a suitable method for detecting zinc sulfate in adulterated urine. Methods: Two rapid spot tests to detect the presence of zinc sulfate in urine were developed. Results: Addition of 3 to 4 drops of 1N sodium hydroxide solution to approximately 1 ml of urine containing zinc sulfate led to the formation of a white precipitate, which was soluble in excess sodium hydroxide. In the second spot test, addition of 3 to 4 drops of 1% sodium chromate solution to 1 ml of urine containing zinc sulfate followed by the addition of 4 to 5 drops of 1N sodium hydroxide led to formation of a yellow precipitate (zinc chromate). Detection limit of these visual spot tests was 10 mg/ml of zinc sulfate in urine. Twenty drug-free urine specimens and urine containing high amounts of sugar or reducing substances were tested with no false-positive spot test results observed. However, if lead is present in high amounts in urine, it may cause false-positive spot test results. When aliquots of urine controls for drugs of abuse testing were supplemented with different amounts of zinc sulfate, false-negative drug test results were observed except for amphetamine. Zinc sulfate also falsely reduced measured urine alcohol level in urine. Conclusions: Zinc sulfate can invalidate urine drug and alcohol testing but can be detected using the novel spot tests developed. Upon completion of this activity you will be able to: list common adulterants used for beating drug tests. define role of newly introduced urinary adulterant zinc sulfate in invalidating immunoassays used for screening abused drugs in urine. defining role of zinc sulfate in causing falsely lowered urine alcohol level. apply newly developed spot tests for zinc sulfate to screen urine specimens submitted for drugs of abuse testing. identify which urine specimens (emergency room patient versus physician office) should be subjected to spot test. The ASCP is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASCP designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit per article. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity qualifies as an American Board of Pathology Maintenance of Certification Part II Self-Assessment Module. The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose. Questions appear on p 595. Exam is located at Alcohol and drug abuse is a significant public health issue in the United States and many countries worldwide. It is estimated that 18 million Americans abuse alcohol, while an estimated 22.6 million Americans (8.9% of the US population) 12 years or older are current illicit drug users. 1 Illicit drugs abused by Americans include marijuana/ hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychoactive drugs obtained illegally without a valid prescription. Marijuana is the most commonly used illicit drug; cocaine abuse continues to be widespread among the general population. 1 On September 15, 1986, President Reagan issued Executive Order directing all federal employees involved in law enforcement, national security, protection of life and property, public health and safety, and other functions requiring a high degree of 572 Am J Clin Pathol 2013;140: DOI: /AJCP2FJ9VBPXJYTQ Welsh_ indd 572
2 public trust to be subjected to mandatory drug testing. Following this executive order, the US Department of Health and Human Services developed guidelines, and Congress passed the Drug Free Workplace Act in Urine is the preferred specimen in preemployment drug testing, and urine specimens are screened for the presence of abused drugs using immunoassays approved by the Food and Drug Administration. No further testing is performed if a urine screen is negative. However, confirmation should be performed for immunoassay-positive specimens by a second technique, preferably by gas chromatography/mass spectrometry (GC/ MS). 2 Workplace drug testing is also common among private employers because such practice can prevent accidents. Gerber and Yacoubian 3 assessed the impact of drug testing within the construction industry and concluded that companies with drug testing programs experienced a 51% reduction in injury incident rates within 2 years of implementation. People try to beat drug tests by either ingesting a detoxifying agent or adding adulterant in vitro to a urine specimen after collection. Specimen integrity testing (ph, creatinine, specific gravity, and temperature) is useful in identifying these individuals trying to beat the drug test. A detoxifying agent results in diluted urine that can be identified by low creatinine in urine. Several household chemicals are used to invalidate drugs of abuse testing in urine. The most commonly used chemicals include table salts (sodium chloride), vinegar, Drano, Joy, hand soap, liquid laundry bleach, denture cleansing tablet, lemon juice, ascorbic acid, hydrogen peroxide, and rubbing alcohol (isopropyl alcohol), but specimen integrity testing can identify all such adulterants except Visine eye drops. 4 Various urinary adulterants available on the Internet, such as pyridinium chlorochromate, glutaraldehyde, and potassium nitrite, have been introduced, and these adulterants can successfully invalidate the immunoassay for various drugs of abuse as well as for GC/MS confirmation of the marijuana metabolite (tetrahydrocannabinol carboxylic acid). However, these adulterants can be detected by spot tests or by using specially designed urine dipsticks, such as AdultaCheck 6 (Sciteck Diagnostics, Arden, NC) and Intect 7 (Branan Medical Group, Irvine, CA) Zinc sulfate has recently been promoted as an effective urinary adulterant to invalidate drug tests by several websites that provide tips to beat drug testing. Venkatratnam and Lents 13 reported that zinc sulfate is an effective urinary adulterant that can produce false-negative results using an enzyme-linked immunosorbent assay for methamphetamine, cocaine (tested as benzoylecgonine), and marijuana. Zinc sulfate at a concentration of 10 to 15 mg/ml is sufficient to achieve false-negative results. The authors further commented that no method is available to detect the presence of zinc sulfate in adulterated urine, including the recently introduced AdultaCheck 10 dipstick for detecting urinary adulterants. 13 Therefore, novel spot tests were developed to detect the presence of zinc sulfate in urine. The data presented here also indicate that zinc sulfate may invalidate additional drugs of abuse testing and showed negative interference (falsely lower values) with urine alcohol testing. Materials and Methods Zinc sulfate, sodium hydroxide, and sodium chromate were obtained from Sigma (St Louis, MO). In addition, albumin (Sigma), creatinine (Fisher Scientific, Waltham, MA), urea (Fisher Scientific), calcium chloride (Fisher Scientific), magnesium sulfate (Fisher Scientific), cobalt chloride (Sigma), copper sulfate (Sigma), ferric chloride (Fisher Scientific), nickel sulfate (Sigma), and lead nitrate (Sigma) were also purchased to perform potential interferences of these substances with spot tests for zinc sulfate. Drugs of abuse tests were performed using reagent kits (EMIT II Plus) obtained from Siemens Diagnostics (Deer Park, IL), and tests were run using the Vista 1500 analyzer (Siemens Diagnostics) with the protocol recommended by the manufacturer. Urine alcohol level was also determined by using the Vista 1550 analyzer with an enzymatic alcohol assay kit obtained from Siemens Diagnostics. Intect 7 urine test strips were purchased from Branan Medical Group. Urine pools were prepared from specimens submitted to our hospital laboratory for drugs of abuse testing. These specimens were retained for a week after reporting results to ordering physicians before being used for this investigation; all specimens were deidentified and considered discarded specimens according to the protocol approved by the Institutional Review Board at the University of Texas Houston Health Science Center for research using leftover specimens. Stock solutions containing 1% sodium chromate and 1N sodium hydroxide were prepared in deionized water. These 2 solutions were used for the 2 spot tests developed for detecting the presence of zinc sulfate in urine. For the first spot test, addition of 3 to 4 drops (approximately 50 µl) of 1N sodium hydroxide solution to approximately 1 ml of urine containing zinc sulfate led to formation of a white precipitate that was soluble in excess sodium hydroxide (additional drops of sodium hydroxide; µl) Image 1. In the second spot test, addition of 3 to 4 drops of 1% sodium chromate solution to 1 ml of urine containing zinc sulfate followed by addition of 4 to 5 drops of 1N sodium hydroxide led to formation of a yellow precipitate (zinc chromate) (Image 1). In both spot tests, appearances of precipitates are different from urinary sediment. Aliquots of positive control urine containing various abused drugs at approximately 20% more than cutoff concentrations were supplemented with 10, 15, 30, and 50 mg/ Am J Clin Pathol 2013;140: DOI: /AJCP2FJ9VBPXJYTQ 573 Welsh_ indd 573
3 Welsh et al / Novel Spot Tests to Detect Zinc Sulfate in Urine A B C D Image 1 Spot tests to detect zinc sulfate (ZnSO4) in urine. A, Urine containing ZnSO4. B, Sodium chromate spot test. C, Sodium hydroxide spot test. D, Precipitate in the sodium hydroxide spot test becomes soluble with excess sodium hydroxide. Table 1 Cutoff Concentrations and Upper Limits of Detection of Various Immunoassays for Drugs of Abuse on the Vista 1500 Analyzer Drug Cutoff Concentration, Analytical Measurement ng/ml Range, ng/mla Amphetamine 1,000 Barbiturates 200 Benzodiazepines 200 Opiates 300 Benzoylecgonine 300 Marijuana metabolite 50 Methadone 300 Phencyclidine 25 Propoxyphene 300 a Semiquantitative concentration Am J Clin Pathol 2013;140: , , ml of zinc sulfate and reassayed for all drugs of abuse using the Vista 1500 analyzer and EMIT II Plus reagent kits. The cutoff concentration and analytical measurement range of the drugs of abuse analyzed are listed in Table 1. However, the concentrations produced for these drugs are semiquantitative. Results were thus measured before and after supplementation with zinc sulfate for comparison. In another set of experiments, a urine pool was prepared from specimens that tested negative for drugs and then supplemented with various drugs of abuse (Sigma) in concentrations approximately 20% to 30% above the cutoff concentrations; drugs of abuse testing were then conducted. Aliquots of the pool were further supplemented with 10, 15, 30, or 50 mg/ml of zinc sulfate followed by repeated drugs of abuse testing to compare with the original values. In addition, aliquots of discarded patient DOI: /AJCP2FJ9VBPXJYTQ Welsh_ indd 574
4 urine specimens that tested positive for cocaine (tested as benzoylecgonine), opiates, marijuana, or benzodiazepines were supplemented with zinc sulfate, and drug tests were repeated to determine the effect of zinc sulfate on urine specimens that originally tested positive for abused drugs. Finally, the effect of zinc sulfate on the urine alcohol test was performed using 3 specimens that tested positive for alcohol. The alcohol assay on the Vista analyzer is an enzymatic assay using alcohol dehydrogenase enzyme. The analytical measurement range of this assay is 20 to 300 mg/dl of alcohol concentration and produces a quantitative result. To investigate the sensitivity of our spot test to detect zinc sulfate, we supplemented aliquots of a negative urine pool with 0.1, 0.5, 1, 5, 10, 15, 30, and 50 mg/ml of zinc sulfate. Both spot tests were then conducted to investigate whether these spot tests could detect the presence of zinc sulfate at lower concentrations than needed to invalidate immunoassays. These specimens were also tested by Intect 7 urine test strips to evaluate whether Intect 7 could detect zinc sulfate in urine. Twenty negative urine specimens were tested with our spot tests to ensure that the tests did not produce falsepositive results. Urine specimens with a high glucose content or positive for ketone bodies were tested with the spot tests to ensure that they did not produce false-positive results in the presence of high glucose and ketone bodies. Furthermore, the possible interference of high levels of albumin, creatinine, urea, calcium chloride, magnesium sulfate, cobalt chloride, copper sulfate, ferric chloride, nickel sulfate, and lead nitrate was assessed by addition of these agents to urine at concentrations of 10 mg/ml, followed by performing the spot tests. Results Venkatratnam and Lents 13 demonstrated that zinc sulfate at a concentration of 10 to 15 mg/ml is effective in interfering with cocaine, methamphetamine, and tetrahydrocannabinol tests. Aliquots of a negative urine pool were supplemented with increasing amounts of zinc sulfate (0.1, 0.5, 1, 5, 10, 15, 30, and 50 mg/ml) to investigate if the spot tests developed could detect the presence of zinc sulfate in urine at lower concentrations than needed to invalidate drug testing. Unambiguous positive responses with both spot tests were observed when zinc sulfate was present at 10 mg/ml, indicating that these novel spot tests are effective in detecting the presence of zinc sulfate in urine at the concentration required to invalidate drug tests. Because these spot tests are visual, requiring subjective interpretation, the detection limit was established at 10 mg/ml of zinc sulfate concentration because changes are obvious at this concentration. In the presence of excess zinc sulfate (50 mg/ml), almost 1 ml of sodium hydroxide was needed for dissolving white precipitate. For the sodium chromate spot test, an excessive amount of yellow precipitate was formed if zinc sulfate was present in excessive concentration (50 mg/ml). In contrast, the presence of zinc sulfate in urine was not detected using Intect 7 test strips even with 50 mg/ml of zinc sulfate. Venkatratnam and Lents 13 studied the effect of zinc sulfate on testing for 3 drugs of abuse. However, 9 drugs (amphetamine, barbiturates, opiates, benzodiazepines, marijuana metabolite, methadone, benzoylecgonine, phencyclidine, and propoxyphene) are routinely analyzed in our institution. Therefore, the effect of zinc sulfate on testing all these drugs was investigated. Zinc sulfate at a concentration of 10 mg/ml, as reported by Venkatratnam and Lents, was used for this study, as well as increasing zinc sulfate concentrations. When aliquots of drug of abuse control urine containing drugs at approximately 20% above the cutoff concentration were supplemented with 10 mg/ml of zinc sulfate, only benzoylecgonine and phencyclidine tests became negative. However, in the presence of 15 mg/ml of zinc sulfate, opiate and marijuana metabolite tests were also negative in addition to benzoylecgonine and phencyclidine. All drugs of abuse tests were negative except for amphetamine with the highest concentration of zinc sulfate (50 mg/ml) Table 2. Similar results were observed when increasing concentrations of zinc sulfate were added to aliquots of a drug-free urine pool supplemented with abused drugs (or metabolites) followed by repeated drugs of abuse testing. Testing for marijuana metabolite showed negative results in the presence of 10 mg/ml of zinc sulfate, and all drugs tests were negative except for amphetamine with 50 mg/ml of zinc sulfate Table 3. In addition, 4 urine specimens that tested positive for cocaine (tested as benzoylecgonine), opiates, benzodiazepines, and marijuana (tested as marijuana metabolite) were selected. Two specimens were specifically selected for each drug in which the semiquantitative drug levels were 20% to 50% above the cutoff concentrations and another 2 specimens for each drug in which the drug levels were at the upper end of the analytical measurement range or above it. Aliquots of each specimen were supplemented with zinc sulfate and retested. When any drug was present 20% to 50% above the cutoff, zinc sulfate was able to produce negative results at various concentrations. However, when a drug was present at a level near the upper end of the analytical measurement range or above the range, zinc sulfate even at a 50 mg/ml concentration was not able to produce negative results, although semiquantitative drug values were significantly reduced. Therefore, zinc sulfate is an effective in vitro adulterant if a drug is present modestly over the cutoff concentration. Because urine alcohol testing is also a frequently ordered test in our laboratory, the effect of zinc sulfate on the determination of alcohol concentration using the Vista 1500 analyzer was investigated. Urine alcohol testing produces a Am J Clin Pathol 2013;140: DOI: /AJCP2FJ9VBPXJYTQ 575 Welsh_ indd 575
5 Welsh et al / Novel Spot Tests to Detect Zinc Sulfate in Urine Table 2 Effect of Adding Zinc Sulfate to Aliquots of Urine Drugs of Abuse Controls on Drugs of Abuse Testing Using the Vista 1500 Analyzer Drug Concentration, ng/ml (Semiquantitative) Specimen Amph Barb Opiate Benz THC MTD BE PCP PPX Control 1,201 (Pos) 333 (Pos) 384 (Pos) 313 (Pos) 58 (Pos) 373 (Pos) 313 (Pos) 29 (Pos) 386 (Pos) + 10 mg/ml ZnSO 4 1,167 (Pos) 313 (Pos) 323 (Pos) 259 (Pos) 55 (Pos) 314 (Pos) 267 (Neg) 22 (Neg) 346 (Pos) + 15 mg/ml ZnSO 4 1,082 (Pos) 303 (Pos) 56 (Neg) 232 (Pos) 44 (Neg) 301 (Pos) 240 (Neg) 19 (Neg) 338 (Pos) + 30 mg/ml ZnSO 4 1, (Pos) <50 (Neg) 161 (Neg) 39 (Neg) 302 (Pos) 151 (Neg) <5 (Neg) 320 (Pos) + 50 mg/ml ZnSO 4 1,013 (Pos) <20 (Neg) <50 (Neg) <30 (Neg) <15 (Neg) 295 (Neg) <35 (Neg) <5 (Neg) 110 (Neg) Amph, amphetamines; Barb, barbiturates; BE, benzoylecgonine, major metabolite of cocaine; Benz, benzodiazepines; MTD, methadone; Neg, negative test result (value below cutoff concentration of a drug); PCP, phencyclidine; Pos, positive test result; PPX, propoxyphene; THC, tetrahydrocannabinol (marijuana metabolite); ZnSO 4, zinc sulfate. Table 3 Effect of Negative Urine Supplemented With Various Drugs and Increasing Concentrations of Zinc Sulfate on Drugs of Abuse Testing Using the Vista 1500 Analyzer Drug Concentration, ng/ml (Semiquantitative) Specimen Amph Barb Opiate Benz THC BE PCP PPX Urine supplemented with drugs 1,271 (Pos) 262 (Pos) 596 (Pos) 297 (Pos) 57 (Pos) 535 (Pos) 50 (Pos) 498 (Pos) + 10 mg/ml ZnSO 4 1,138 (Pos) 238 (Pos) 323 (Pos) 252 (Pos) 25 (Neg) 414 (Pos) 38 (Pos) 448 (Pos) + 15 mg/ml ZnSO 4 1,118 (Pos) 231 (Pos) 291 (Neg) 263 (Pos) <15 (Neg) 384 (Pos) 29 (Pos) 412 (Pos) + 30 mg/ml ZnSO 4 1,032 (Pos) 67 (Neg) <50 (Neg) 32 (Neg) <15 (Neg) 252 (Pos) <5 (Neg) <5 (Neg) + 50 mg/ml ZnSO 4 1,016 (Pos) <20 (Neg) <50 (Neg) <30 (Neg) <15 (Neg) <35 (Neg) <5 (Neg) <0 (Neg) Amph, amphetamines; Barb, barbiturates; BE, benzoylecgonine, major metabolite of cocaine; Benz, benzodiazepines; Neg, negative test result (value below cutoff concentration of a drug); PCP, phencyclidine; Pos, positive test result; PPX, propoxyphene; THC, tetrahydrocannabinol (marijuana metabolite); ZnSO 4, zinc sulfate. Table 4 Effect of Adulteration of Alcohol-Positive Urine With Zinc Sulfate on Alcohol Testing Using the Vista 1500 Analyzer Specimen Alcohol Concentration, mg/dl Specimen mg/ml ZnSO mg/ml ZnSO mg/ml ZnSO mg/ml ZnSO 4 Specimen mg/ml ZnSO mg/ml ZnSO mg/ml ZnSO mg/ml ZnSO 4 38 Specimen mg/ml ZnSO mg/ml ZnSO mg/ml ZnSO mg/ml ZnSO 4 ZnSO 4, zinc sulfate. quantitative result in contrast to urine drug testing, which provides a semiquantitative result. Significant declines in urinary alcohol concentration in the presence of zinc sulfate using the Vista 1500 analyzer were observed Table 4. The specimen containing 25 mg/dl of alcohol produced negative results (<20 mg/dl, the detection limit of the assay) in the presence of 15 mg/ml of zinc sulfate. The specimen containing 76 mg/ dl of alcohol showed a negative result in the presence of 50 mg/ml of zinc sulfate. However, the specimen containing 130 mg/dl of alcohol tested positive even in the presence of 50 mg/ml of zinc sulfate, although the value was significantly reduced. To our knowledge, negative interference of zinc sulfate in urine alcohol testing has not been reported. Specimen integrity testing (ph, creatinine, temperature, and specific gravity) is useful in identifying various household chemicals that are added to urine to invalidate drugs of abuse testing. The change in specific gravity of urine upon the addition of increasing amounts of zinc sulfate was investigated. Unfortunately, specific gravity did not change significantly even after supplementing urine specimens with 50 mg/ml of zinc sulfate, the highest zinc sulfate concentration studied. For example, the specific gravity of a urine specimen was The specific gravity increased to only in the presence of 10 mg/ml of zinc sulfate, and the specific gravity was in the presence of 50 mg/ml of zinc sulfate, which was significantly below the cutoff. Therefore, specimen integrity testing cannot identify the presence of zinc sulfate in urine. In addition, we observed insignificant lowering of urine ph in the presence of zinc sulfate (even 50 mg/ml), indicating that specimen integrity testing is not useful in detecting urine specimens adulterated with zinc sulfate. Our results are consistent with observations by Venkatratnam and Lents. 13 To ensure that ketone bodies or high glucose if present in urine do not interfere with these spot tests, we evaluated urine specimens that showed high glucose content or were positive for ketone bodies using our spot tests. No positive 576 Am J Clin Pathol 2013;140: DOI: /AJCP2FJ9VBPXJYTQ Welsh_ indd 576
6 response was observed, indicating that high glucose or ketone bodies do not interfere with these spot tests. Furthermore, 20 negative urine specimens were tested with both spot tests, and no false-positive response was observed. The potential interference of albumin, creatinine, urea, calcium, magnesium, cobalt, copper, iron, nickel, and lead also was assessed Table 5. High levels (10 mg/ml) of albumin, creatinine, and urea did not interfere with either spot test. Calcium, cobalt, copper, iron, and nickel resulted in the formation of precipitates with the sodium hydroxide spot test; however, the precipitates formed were not soluble in excess sodium hydroxide. Only lead produced a false-positive spot test. We selected a 10 mg/ ml concentration of all these interfering substances because the detection limit of zinc sulfate spot tests is 10 mg/ml. However, these high concentrations for these interfering substances are unlikely in a clinical situation. Discussion After the US Congress passed the Drug Free Workplace Act in 1988 that resulted in Mandatory Guidelines for Federal Workplace Drug Testing Programs, there have been many scientific and legal challenges to the validity of urine drug testing. In response, the Substance Abuse and Mental Health Services Administration (SAMHSA) put forth many revisions, strict procedural guidelines, and specimen validity testing criteria to manage suspicious and adulterated samples during and after urine collection. 14 Because many adulterants can invalidate immunoassay screening of various drugs, it is important to identify such adulterated specimens prior to testing; if immunoassay screening is negative, GC/MS identification is not conducted. According to SAMHSA guidelines, no further testing is necessary if a specimen is adulterated. Consequently, a job can be denied to an individual submitting an adulterated specimen. Venkatratnam and Lents 13 already demonstrated that zinc sulfate can interfere with methamphetamine, cocaine, and marijuana testing. Moreover, the authors commented that no test is currently available that can detect the presence of zinc sulfate in adulterated urine. Therefore, 2 rapid spot tests were developed in this report for detecting the presence of zinc sulfate in urine. In addition, our results also indicate that zinc sulfate at 10 mg/ml can invalidate the phencyclidine test. Furthermore, opiate, marijuana metabolite, benzoylecgonine, and phencyclidine tests were negative with the addition of 15 mg/ml of zinc sulfate. At a 50 mg/ml zinc sulfate concentration, barbiturate, benzodiazepine, opiate, marijuana metabolite, methadone, benzoylecgonine, phencyclidine, and propoxyphene tests were also negative. However, in contrast to the observations of Venkatratnam and Lents, the amphetamine test was not affected in this investigation. This may be related to the use of a different immunoassay for testing amphetamine. Our study indicated that zinc sulfate is effective in producing false-negative test results with 8 common drugs of abuse tests. In addition, zinc sulfate can significantly interfere with the urine alcohol test, producing falsely lower values. However, zinc sulfate was ineffective in invalidating drug testing when drugs were present at a very high concentration in urine (near the upper end of the analytical measurement range or above). Since zinc sulfate is an effective adulterant, it is important to identify it prior to immunoassay screening. The Adulta- Check 10 urine test strip is not effective in identifying zinc sulfate. 13 The study reported here further indicates that another urine test strip, Intect 7, is also not capable of detecting the presence of zinc sulfate in urine even if present in a very high concentration. However, these novel spot tests can effectively identify the presence of zinc sulfate in urine. The first spot test is fairly specific for identifying zinc ion in urine because zinc ion has the unique feature of forming a white precipitate of zinc hydroxide in the presence of sodium hydroxide, which is soluble in excess sodium hydroxide. The second spot test consists of a yellow precipitate generated due to the formation of zinc chromate; this test is also specific for zinc because the Table 5 Visual Changes of Various Substrates (10 mg/ml) Using the Spot Tests for Zinc Sulfate Substrate Sodium Hydroxide Spot Test Sodium Chromate Spot Test Albumin No effect No effect Creatinine No effect No effect Urea No effect No effect Calcium chloride White precipitate, insoluble in excess NaOH No effect Cobalt chloride Blue precipitate, insoluble in excess NaOH Rust color precipitate Copper sulfate Blue precipitate, insoluble in excess NaOH Green precipitate Ferric chloride Red precipitate, insoluble in excess NaOH Red color Lead nitrate a White precipitate, soluble in excess NaOH Yellow precipitate Magnesium sulfate Cloudy, no precipitate No effect Nickel sulfate White precipitate, insoluble in excess NaOH No effect NaOH, sodium hydroxide. a Results similar to zinc sulfate spot test, but lead salt concentration of 10 mg/ml in urine is highly unlikely even after lead poisoning. Am J Clin Pathol 2013;140: DOI: /AJCP2FJ9VBPXJYTQ 577 Welsh_ indd 577
7 Welsh et al / Novel Spot Tests to Detect Zinc Sulfate in Urine other chromate salts that are insoluble in water have a much darker yellow color, although some chromate salts such as potassium chromate are water soluble and yellow. Only lead was found to produce a false-positive result with the spot tests we developed. Fortunately, elevated blood lead levels are rare, occurring in approximately 6.3 per 100,000 adults. 15 In addition, urine lead levels in adults with lead poisoning were reported to be significantly lower than the levels needed to cause a false-positive spot test in this investigation. 16 We did not investigate the exact mechanism by which zinc sulfate interferes with both drugs of abuse testing and alcohol testing. In EMIT II Plus assays of drugs of abuse and the enzymatic alcohol assay, the signal is measured at 340 nm, which is generated due to conversion of nicotinamide adenine dinucleotide (NAD) into NADH. Possibly zinc sulfate interacts with NADH and, through the redox reaction, converts it back to NAD, and thus absorption at 340 nm is reduced. Novel spot tests for detecting zinc sulfate in urine are not conclusive for the presence of zinc ion in the urine specimen. Further testing to confirm the presence of excess zinc in urine may be needed to meet specific medical and legal situations. The presence of a high amount of zinc in urine can be confirmed by atomic absorption spectrophotometry. More recently, inductively coupled plasma mass spectrometry (ICP-MS) has been found useful for unambiguous identification and quantification of zinc and other elements in urine. 17 Therefore, ICP-MS can also be used for further testing of urine specimens tested positive by spot tests. It was concluded that the 2 novel tests developed are effective in identifying the presence of zinc sulfate as an adulterant in urine. Address reprint requests to Dr Dasgupta: Dept of Pathology and Laboratory Medicine, University of Texas Houston Medical School, 6431 Fannin, MSB 2.292, Houston, TX 77030; amitava.dasgupta@uth.tmc.edu. References 1. US Department of Health and Human Services. Results From the 2010 National Survey on Drug Use and Health: National Findings. Washington, DC: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies; Bush D. The US mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int. 2008;174: Gerber JK, Yacoubian GS Jr. An assessment of drug testing within the construction industry. J Drug Educ. 2002;32: Warner A. Interference of household chemicals in immunoassay methods for drugs of abuse. Clin Chem. 1989;35: Wu A, Bristol B, Sexton K, et al. Adulteration of urine by Urine Luck. Clin Chem. 1999;45: Wu AH, Forte E, Casella G, et al. CEDIA for screening drugs of abuse in urine and the effect of adulterants. J Forensic Sci. 1995;40: Goldberger BA, Caplan YH. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay [letter]. Clin Chem. 1994;40: Wu A, Schmalz J, Bennett W. Identification of Urin-Aid adulterated urine specimens by fluorometric analysis [letter]. Clin Chem. 1994;40: Peace MR, Tarnai LD. Performance evaluation of three on-site adulteration detection devices for urine specimens. J Anal Toxicol. 2002;26: King EJ. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs of abuse testing. J Anal Toxicol. 1999;23: Dasgupta A, Wahed A, Wells A. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing. Am J Clin Pathol. 2002;117: Dasgupta A, Chughtai O, Hannah C, et al. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens. Clin Chem Acta. 2004;34: Venkatratnam A, Lents NH. Zinc reduces the detection of cocaine, methamphetamine, and THC by ELISA urine testing. J Anal Toxicol. 2011;35: Phan HM, Yoshizuka K, Murry DJ, et al. Drug testing in the workplace. Pharmacotherapy. 2012;32: Centers for Disease Control and Prevention. Adult blood lead epidemiology and surveillance United States, MMWR Morb Mortal Wkly Rep. 2009;58: Balali-Mood M, Shademanfar S, Rastegar Moghadam J, et al. Occupational lead poisoning in workers of traditional tile factories in Mashhad, northeast of Iran. Int J Occup Environ Med. 2010;1: Wang J, Harald Hansen E, Gammelgaard B. Flow injection on-line dilution for multi-element determination in human urine with detection by inductively coupled plasma mass spectrometry. Talanta. 2001;55: Am J Clin Pathol 2013;140: DOI: /AJCP2FJ9VBPXJYTQ Welsh_ indd 578
Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing
Clinical Chemistry / SPOT TESTS TO DETECT ADULTERANTS IN URINE SPECIMENS Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing Amitava Dasgupta, PhD,
More informationZinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing
Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing Abhishek Venkatratnam and Nathan H. Lents* Department of Sciences, John Jay College of Criminal Justice, The City
More informationBeating Drug Tests and Defending Positive Results
Beating Drug Tests and Defending Positive Results Amitava Dasgupta Beating Drug Tests and Defending Positive Results A Toxicologist s Perspective Amitava Dasgupta Department of Pathology and Laboratory
More informationEDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing
EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE
More informationTHE EFFECTIVENESS OF THE ALERE ISCREEN URINE ADULTERATION TEST STRIP AT DETECTING SIX COMMON URINE ADULTERANTS. Carrie Beard
THE EFFECTIVENESS OF THE ALERE ISCREEN URINE ADULTERATION TEST STRIP AT DETECTING SIX COMMON URINE ADULTERANTS by Carrie Beard A Senior Honors Project Presented to the Honors College East Carolina University
More informationQuickTox Drug Screen Dipcard (with and without Adulteration Tests)
QuickTox Drug Screen Dipcard (with and without Adulteration Tests) Training and Certification Program Presented by Branan Medical Corporation Branan Medical Corporation 10015 Muirlands Road Irvine, California
More informationQuickTox Drug Screen Dipcard (with and without Adulteration Tests)
QuickTox Drug Screen Dipcard (with and without Adulteration Tests) Training and Certification Program Presented by CLIAwaived.com, San Diego, CA Distributed by CLIAwaived.com www.cliawaived.com 1-858-481-5031
More informationEffects of Stealtff Adulterant on Immunoassay Testing for Drugs of Abuse*
Journal of Analytical Toxicology, Vo]. 25, September 2001 [ TechnicalNote Effects of Stealtff Adulterant on Immunoassay Testing for Drugs of Abuse* John T. Cody t Academy of Health Sciences, MCCS-HMP PA
More informationElevated Urine Zinc Concentration Reduces the Detection of Methamphetamine, Cocaine, THC and Opiates in Urine by EMIT
Journal of Analytical Toxicology 2013;37:665 669 doi:10.1093/jat/bkt056 Advance Access publication July 10, 2013 Article Elevated Urine Zinc Concentration Reduces the Detection of Methamphetamine, Cocaine,
More informationToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program
ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program ToxCup Training Page 1 of 8 Rev. B ToxCup Drug Screen Cup ToxCup Drug Screen Cup with Adulteration Tests
More information2013 Clinical drug and alcohol testing solutions. Product Catalog. CLIA-waived point of care test devices
2013 Clinical drug and alcohol testing solutions Product Catalog CLIA-waived point of care test devices HELPING YOU MAKE INFORMED DECISIONS ABOUT ABUSE. Substance abuse testing with more substance. 2 of
More informationRapid Alcohol Screening Devices. p19
CLIA-WAIVED Product Catalog RAPID DRUG SCREENING DEVICES Rapid Urine Drug Screening Devices. p5 Rapid Alcohol Screening Devices. p19 Complementary Products. p23 HELPING YOU MAKE INFORMED DECISIONS ABOUT
More informationToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program
ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program ToxCup Training Page 1 of 8 Rev. B ToxCup Drug Screen Cup ToxCup Drug Screen Cup with Adulteration Tests
More informationNEW YORK STATE DEPARTMENT OF HEALTH CLINICAL LABORATORY EVALUATION PROGRAM
Any Forensic Toxicology standards not addressed here remain in effect. (changes are underlined) Forensic Toxicology Sustaining Standard of Practice 27 (FT S27): Urine SVT Calibration and QC Requirements
More informationT R A I N I N G G U I D E
TRAINING GUIDE InstaCube Oral Fluid Drug Test For Forensic Use Only Powered By: Contents 3 The information in this presentation is a general overview on performing and interpreting the InstaCube Oral Fluid
More informationYou Can t Fool the Bladder Police. Effective Use of Urine Drug Screening
You Can t Fool the Bladder Police Effective Use of Urine Drug Screening Why Test? Accountability Create and maintain safe treatment environment Compliance with licensing or policy Collection Supervised
More informationDrug Testing: How to Evaluate Results
Drug Testing: How to Evaluate Results Prepared for you by the West Virginia Drug Testing Laboratory Drug testing, whether for an individual or a large corporation, consists of two necessary steps - specimen
More informationQuest Diagnostics Drug Testing Index Full Year 2015 Tables
Quest Diagnostics Drug Testing Index Full Year 2015 Tables Table 1. Annual Positivity Rates Urine Drug Tests (For Combined U.S. Workforce) (More than 9.5 million tests from January to December 2015) Year
More informationTesting for Controlled Substances
Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug
More informationEDUCATIONAL COMMENTARY METHADONE
EDUCATIONAL COMMENTARY METHADONE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing Education
More informationFastect II Drug Screen Dipstick Test Training and Certification Program
Fastect II Drug Screen Dipstick Test Training and Certification Program Fastect II Training Page 1 of 7 Rev. B Fastect II Drug Screen Dipstick Test Training and Certification for Test Administrators The
More informationCutoff levels for hydrocodone in a blood test
Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.
More informationLearning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly
Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the
More informationAdulteration of Urine by Urine Luck
Clinical Chemistry 45:7 1051 1057 (1999) Drug Monitoring and Toxicology Adulteration of Urine by Urine Luck Alan H.B. Wu, 1* Ben Bristol, 1 Karen Sexton, 1 Gina Cassella-McLane, 1 Verena Holtman, 1 and
More informationFrequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up
Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty
More informationIllicit Drug Positivity Rate Increases Sharply in Workplace Testing, Finds Quest Diagnostics Drug Testing Index Analysis
News from Quest Diagnostics Contacts: Wendy Bost, Quest Diagnostics (Media): 973-520-2800 Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900 Illicit Drug Positivity Rate Increases Sharply in Workplace
More informationProduct Catalog. Rapid Alcohol Screening Devices. p24. Rapid Urine Screening Devices. p4. Rapid Oral Fluid Screening Devices. p18
2014 Product Catalog Rapid Urine Screening Devices. p4 Rapid Oral Fluid Screening Devices. p18 Rapid Alcohol Screening Devices. p24 Complementary Products. p32 Product Catalog HELPING YOU MAKE INFORMED
More informationPayment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:
Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important
More informationSmartNotes. Understanding the SAMHSA Guidelines for Drugs of Abuse Testing
DIAGNOSTICS SAMHSA Guidelines SmartNotes Understanding the SAMHSA Guidelines for Drugs of Abuse Testing The Substance Abuse and Mental Health Services Administration (SAMHSA) is an agency within the US
More informationProduct Training & Certification
B R A N A N M E D I C A L C O R P O R A T I O N Product Training & Certification Oratect III Oral Fluid Drug Screen Device Catalog # HM11 & HM12 For Forensic Use Only Branan Medical Corporation 140 Technology
More informationThe Effects of Adulterants and Selected Ingested Compounds on Drugs-of-Abuse Testing in Urine
Clinical Chemistry / URINARY ADULTERANTS AND DRUGS-OF-ABUSE TESTING The Effects of Adulterants and Selected Ingested Compounds on Drugs-of-Abuse Testing in Urine Amitava Dasgupta, PhD Key Words: Adulterants;
More informationDRUGS OF ABUSE
DRUGS OF ABUSE www.btnx.com 1-888-339-9964 Rapid Response Drugs of Abuse and Alcohol Screening Devices BTNX Inc. prides itself in offering quality drug detection tests for accurate, safe and rapid testing.
More informationProduct Training & Certification
Product Training & Certification Oratect Oral Fluid Drug Screen Device For Professional Point of Care Use Oratect Training Page 1 of 12 MKT-045 (C) Oratect Oral Fluid Drug Screen Device Training and Certification
More informationWhy Drug Test in the Retail Industry? 2010 Retail Inventory Shrinkage 3. Employee Theft $16.2B (43.7%)
Why Drug Test in the Retail Industry? ~1 out of 10 full-time employees uses illicit drugs. 1 80% of drug abusers steal from their workplace. 2 Employee theft accounts for >43% of retail shrinkage: an annual
More informationDrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.
DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide The information in this presentation is a general overview on using Confirm BioSciences DrugConfirm Advanced urine drug test cup; however,
More informationNews From Quest Diagnostics
Quest Diagnostics Incorporated 1290 Wall Street West Lyndhurst, NJ 07071 Quest Diagnostics Contacts: Laure Park (Investors): 201-393-5030 Jennifer Somers (Media): 201-393-5700 News From Quest Diagnostics
More informationSlide into easier drug testing in Answers to 5 Frequently Asked Drug Test Questions
Slide into easier drug testing in 2013 Answers to 5 Frequently Asked Drug Test Questions About Your Presenter Melissa DiThomas Melissa.Dithomas@lexisnexis.com +1.724.742.0485 2 5 Top Questions Asked What
More informationWhat Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital
What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.
More informationSmartNotes. Thermo Scientific Specimen Validity Tests for Drugs of Abuse Testing
DIAGNOSTICS s SmartNotes Thermo Scientific s for Drugs of Abuse ing for Urine Tampering Using s Urine is the most commonly used specimen for drugs of abuse testing. This is primarily because urine is readily
More informationOralTox instant oral fluid drug testing
OralTox instant oral fluid drug testing Frequently asked questions Q: Why drug test? A: Drug abuse in the workplace puts employers at risk of increased accidents, more absenteeism, lower productivity,
More informationDrug Testing Index. A comprehensive analysis of workplace drug use trends
Drug Testing Index A comprehensive analysis of workplace drug use trends Employer Solutions Annual Report Fall 2016 Table of contents Analysis Drug Positivity in U.S. Workforce Rises to Highest Level in
More informationMarijuana Positivity Increases 6.2 Percent Nationally in Urine Drug Tests, but by Double Digits in Colorado and Washington
News from Quest Diagnostics Contacts: Wendy Bost, Quest Diagnostics (Media): 973-520-2800 Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900 Workforce Drug Test Positivity Rate Increases for the
More informationNews From Quest Diagnostics
Quest Diagnostics Incorporated One Malcolm Avenue Teterboro, New Jersey 07608 News From Quest Diagnostics Contacts: Jennifer Somers (Media): 201-393-5454 Laure Park (Investors): 201-393-5030 FOR IMMEDIATE
More informationUrine Drug Testing, Advantages and Disadvantages. Advantages
overview [chemistry] Urine Drug Testing: Approaches to Screening and Confirmation Testing Gifford Lum, MD, Barry Mushlin, MA VA Boston Healthcare System, Boston, MA DOI: 10.1309/QHJCKA4235EGPEGF 368 Most
More informationNews From Quest Diagnostics
Quest Diagnostics Incorporated 1290 Wall Street West Lyndhurst, New Jersey 07071 Quest Diagnostics Contacts: Laure Park (Investors): 201-393-5030 Jennifer Somers (Media): 201-729-8386 News From Quest Diagnostics
More informationNews From Quest Diagnostics
Quest Diagnostics Incorporated One Malcolm Avenue Teterboro, New Jersey 07608 News From Quest Diagnostics Quest Diagnostics Contacts: Laure Park (Investors): 201-393-5030 Jennifer Somers (Media): 201-393-5700
More informationTest Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine
Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and
More informationClinical Policy: Outpatient Testing for Drugs of Abuse Reference Number: PA.CP.MP.50
Clinical Policy: Reference Number: PA.CP.MP.50 Effective Date: 01/18 Last Review Date: 09/17 Coding Implications Revision Log Description Urine drug testing is a key diagnostic and therapeutic tool that
More information! "##$ %%& Colonial Scientific 8439 Glazebrook Drive Richmond, Virginia 23228
!! "##$ %%& & % % Drug Screening Tests Specimen Cups Colonial Scientific 8439 Glazebrook Drive Richmond, Virginia 23228 ITEM # DESCRIPTION UM PRICE DR0201 2-Panel Test Cocaine, Marijuana 25/CS CS $90.00
More informationDate. Measurements of cocaine and cocaine metabolites are used in the diagnosis and treatment of cocaine use or overdose.
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Cocaine Metabolite REF 475003 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE
More informationLaboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
More informationEffective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)
1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory
More informationHawaii, Arkansas and Oklahoma Lead the Nation for Methamphetamine Use in the Workforce, Reveals Quest Diagnostics Drug Testing Index
For immediate release: Media Contact: Barb Short 973-520-2800 Investor Contact: Kathleen Valentine 973-520-2900 Hawaii, Arkansas and Oklahoma Lead the Nation for Methamphetamine Use in the Workforce, Reveals
More informationUrine drug testing it s not always crystal clear
Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine
More informationUrine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
More informationOpiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided
Opiates Rapid Test Cat. No.:DTS137 Pkg.Size:50T Intended use The CD One Step Opiates Screening Test is a rapid, qualitative immunoassay for the detection of opiates and opiate metabolites in urine. The
More informationDRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None
DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.3 T0 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF
More informationDrugConfirm Advanced Urine Dip Cards.
DrugConfirm Advanced Urine Dip Cards The information in this presentation is a general overview on using the Confirm BioSciences DrugConfirm Advanced drug test cup but can be applied to many similarly
More informationDRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None
DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.1 T0 Effective Date: October 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES
More informationDrug Screens. 6.1 Drug Testing
Drug Screens 6 In this chapter, drug screens will be briefly discussed keeping in mind different requirements between clinical toxicology concerned with patient management and forensic toxicology. The
More informationMEDICAL POLICY Drug Testing
POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each
More informationDrug Testing Index A comprehensive analysis of workplace drug use trends
Employer Solutions Semi-Annual Report Fall 2013 Drug Testing Index A comprehensive analysis of workplace drug use trends Anniversary DTI The Quest Diagnostics Drug Testing Index is published as a public
More informationInterpretation of Workplace Tests for Cannabinoids
J. Med. Toxicol. (2017) 13:106 110 DOI 10.1007/s13181-016-0587-z PROCEEDINGS Interpretation of Workplace Tests for Cannabinoids Ken Kulig 1 Received: 17 May 2016 /Revised: 16 August 2016 /Accepted: 6 September
More informationOratectPlus Oral Fluid Drug and Alcohol Screen Device Training and Certification Program
OratectPlus Oral Fluid Drug and Alcohol Screen Device Training and Certification Program OratectPlus Training Page 1 of 10 Rev. A OratectPlus Oral Fluid Drug and Alcohol Screen Device Training and Certification
More information2. DEFINITIONS. For the purposes of this policy the following terms are defined herein:
SECTION IV: ALCOHOL AND DRUG FREE WORKPLACE 1. GENERAL POLICY. The purpose of this policy is to implement the Federal Drug Free Workplace Act of 1988 by providing for a safe and productive work environment
More informationWorkforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
News from Quest Diagnostics Media: Kim Gorode, 973.520.2800 Investors: Shawn Bevec, 973.520.2900 Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics
More informationBENZODIAZEPINES / BZO
DrugCheck Waive TM (FP) Multiple Drug Screen Cup Package Insert for testing any combination of the following drugs: AMP/BAR/BZO/COC/THC/MTD/MET/MDMA/OPI300/OPI/OXY/PCP/PPX/TCA Including Specimen Validity
More informationDRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None
DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.2 T0 Effective Date: January 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES
More informationConserving Energy Preserving the Future
Conserving Energy Preserving the Future Drug and Alcohol Policy 1. Introduction Company is committed to providing safe, dependable and economical service to its Sponsor and Sponsor s customers, maintaining
More information3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management
Urine Drug Testing in Chronic Pain Management March 8, 2018 Faculty/Presenter Disclosure Faculty: Andrew J Smith, MDCM Relationships with commercial interests: None to report Andrew J Smith, MDCM Staff
More informationRules and Regulations. Rules and Regulations
Department of Transportation Modes FEDERAL MANDATES 49 CFR PART 40 All modes Procedures for testing Part 382 - FMCSA Testing Rules & Regulations 1 Applicability CDL License & Drives Vehicle Over 26,000
More informationEfficiency Evaluation of Urine Collection Vessels with Impeded Urine Adulteration/Substance of Abuse (SOA) Rapid Detection Test Strips
Research Article imedpub Journals http://www.imedpub.com Journal of Drug Abuse 2471-853X DOI: 10.21767/2471-853X.100051 Abstract Efficiency Evaluation of Urine Collection Vessels with Impeded Urine Adulteration/Substance
More informationSUBSTANCE ABUSE PROGRAM
SUBSTANCE ABUSE PROGRAM The Local Unions signatory to this Agreement and the Port of Seattle have agreed on this Substance Abuse Program ( Program ) for application to all Contractor craft personnel, union
More informationKenosha County Drug and Alcohol Abuse Policy
Kenosha County Drug and Alcohol Abuse Policy Kenosha County is committed to protecting the safety, health and well-being of all employees and other individuals in our workplace. We recognize that alcohol
More informationDRUG TESTS S: THEIR USES AND LIMITATIONS
C H A P T E R 5 DRUG TESTS S: THEIR USES AND LIMITATIONS Introduction In order to ascertain whether an individual has administered drugs of abuse or not, drug testing is commonly employed to check for
More informationContract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)
The services and requirements referenced are specific to Texas Department of Criminal Justice (TDCJ) and are in addition to and may include the services and must be in compliance with the requirements
More information13. Forensic Toxicology, Workplace Testing, Sports Medicine and Related Areas
13. Forensic Toxicology, Workplace Testing, Sports Medicine and Related Areas A. Overview 1. Alcohol, tobacco and illicit drug use declining but still used. a. Alcohol most common, referred to as gateway
More informationNews From Quest Diagnostics
Quest Diagnostics Incorporated One Malcolm Avenue Teterboro, New Jersey 07608 News From Quest Diagnostics Contacts: Jennifer Somers (Media): 201-393-5700 Laure Park (Investors): 201-393-5030 FOR IMMEDIATE
More informationThe Drug Testing Process. Employer or Practice
Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine
More informationA Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS
A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement
More informationControlled Substance Monitoring in the Age of the Opioid Epidemic
Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,
More informationURINE DRUG TOXICOLOGY
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences URINE DRUG TOXICOLOGY Suzanne E. Rapp, MD GENERAL DISCLOSURES The University of Washington School of Medicine also
More informationUrine Drug Testing to Monitor Opioid Use In Managing Chronic Pain
Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing
More informationNews From Quest Diagnostics
Quest Diagnostics Incorporated One Malcolm Avenue Teterboro, New Jersey 07608 Core Brand Special Competencies Of Core Brand Quest Diagnostics Contacts: Laure Park (Investors): 201-393-5030 Jennifer Somers
More informationProcedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager
Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting drug testing results. 2.0 Scope This procedure applies to all submissions
More informationTHC Cannabinoid 100 ng
SYNCHRON System(s) Chemistry Information Sheet 2014 Beckman Coulter, Inc. All rights reserved. THC Cannabinoid 100 ng 445990 For In Vitro Diagnostic Use ANNUAL REVIEW Rx Only Reviewed by Date Reviewed
More informationDrug Testing Policy. Approved By 05/10/2017. Application This reimbursement policy applies to UnitedHealthcare Community Plan Medicaid products.
Policy Number 2017R6005B Annual Approval Date Drug Testing Policy 05/10/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY You are responsible for
More informationPayment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:
Payment Policy Drug Testing EFFECTIVE DATE: 05 23 2013 POLICY LAST UPDATED: 06 05 2018 OVERVIEW This policy documents the criteria and documentation requirements for immunoassay (IA) testing (also called
More informationDrug & Alcohol Testing in. Canada. Point of Care Testing
Drug & Alcohol Testing in Canada Point of Care Testing Introduction We are the leading Canadian innovator of diagnostic testing products and services Verify Diagnostics has assisted governments, corporations,
More informationDrug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee
Reimbursement Policy CMS 1500 Drug Testing Policy Policy Number 2017R6005A Annual Approval Date 05/10/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY
More informationOral fluid drug tests: Effects of adulterants and foodstuffs
Forensic Science International 150 (2005) 175 180 www.elsevier.com/locate/forsciint Oral fluid drug tests: Effects of adulterants and foodstuffs Raphael C. Wong *, Minhchau Tran, James K. Tung Branan Medical
More informationProcedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis
Toxicology Analysis 1.0 Purpose - This procedure specifies the required elements for analyzing toxicology submissions and reporting the results of the analysis. 2.0 Scope This procedure applies to all
More informationCooking Meth and Doctor Shopping: The Challenges of Managing Prescription Therapeutics
Cooking Meth and Doctor Shopping: The Challenges of Managing Prescription Therapeutics James H. Nichols, PhD, DABCC, FACB Professor of Pathology, Microbiology, and Immunology Medical Director, Clinical
More informationConfirm Limit--Level of detectable drugs in urine to confirm a positive test.
Alcohol and Substance Abuse Policy Purpose To establish and maintain a safe, healthy working environment for all PVFD members; reduce the incidence of accidental injury to members and property; reduce
More informationDrug Testing Basics. by Erowid
Drug Testing Basics by Erowid INDEX 1. What do they Test for? 2. Test Types 3. Test Sensitivity 4. Detection Periods WHAT DO THEY TEST FOR? The first thing to know about drug testing is what the standard
More informationMEDICAL POLICY Drug Testing
POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each
More informationCOMPLETE DRUG AND ALCOHOL POLICY & Testing Policy
COMPLETE DRUG AND ALCOHOL POLICY & Testing Policy... Rev 12/2012 1 I. STATEMENT OF POLICY Robért Resources LLC. ( Robért s ) and it s related companies is committed to providing safe, healthful, and efficient
More informationPolicy Title. Control Number HR003. Exception The Scotland County Sheriff s Department is subject to a separate policy.
Purpose To ensure compliance with federal regulations as outlined under the Drug-Free Workplace Act and by the U.S. Department of Transportation; to identify the conditions by which personnel are subject
More informationCOCAINE-QUALITATIVE IMMUNOASSAY (COC) Wedges each contain usable volumes of 23 ml of R1 reagent and 9 ml of R2 reagent.
REF 14241-4 4 x 23 ml/9 ml COCAINE-QUALITATIVE IMMUNOASSAY (COC) Wedges each contain usable volumes of 23 ml of R1 reagent and 9 ml of R2 reagent. INTENDED USE The EasyRA Cocaine (COC) reagent is intended
More informationOP2 PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE
SYNCHRON System(s) Chemistry Information Sheet Copyright 2010 Beckman Coulter, Inc. Opiate 2000 ng REF 475006 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED
More information